Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Regulatory News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.35
Bid: 3.30
Ask: 3.40
Change: 0.00 (0.00%)
Spread: 0.10 (3.03%)
Open: 3.35
High: 3.35
Low: 3.35
Prev. Close: 3.35
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Price Monitoring Extension

22 Sep 2020 16:36

RNS Number : 7768Z
ValiRx PLC
22 September 2020
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PMEBUGDCUXDDGGD
Date   Source Headline
17th Oct 20187:00 amRNSVAL201 in concluding stages of Phase I/II trial
15th Oct 201812:00 pmRNSVAL401 results shortly to be on ClinicalTrials.gov
25th Sep 20187:00 amRNSHalf-year Report
14th Sep 201812:42 pmRNSIssue of Equity
6th Sep 20187:00 amRNSUpdate on Clinical Development
24th Jul 201812:17 pmRNSResult of General Meeting
17th Jul 20187:00 amRNSUS PATENT GRANT FOR THERAPEUTIC COMPOUND, VAL301
6th Jul 20184:42 pmRNSNotice of GM
14th Jun 20187:00 amRNSVAL401 Update
24th May 20189:00 amRNSPrice Monitoring Extension
11th May 20182:56 pmRNSHolding(s) in Company
8th May 201812:13 pmRNSResult of AGM
4th May 20184:40 pmRNSSecond Price Monitoring Extn
4th May 20184:35 pmRNSPrice Monitoring Extension
4th May 20184:01 pmRNSPlacing and grant of warrants
26th Apr 20182:05 pmRNSSecond Price Monitoring Extn
26th Apr 20182:00 pmRNSPrice Monitoring Extension
25th Apr 20184:40 pmRNSSecond Price Monitoring Extn
25th Apr 20184:35 pmRNSPrice Monitoring Extension
25th Apr 20187:00 amRNSEU Patent Grant for Therapeutic Compound, VAL201
20th Apr 201810:45 amEQSHardman & Co Research: ValiRx (VAL): 2017: a pivotal year
19th Apr 20187:00 amRNSGENEICE & VAL101 Update
12th Apr 20187:00 amRNSNotice of AGM
10th Apr 20187:00 amRNSFinal Results
20th Mar 20187:00 amRNSUS Patent Grant for Therapeutic Compound, VAL201
19th Mar 20187:00 amRNSHolding(s) in Company
16th Mar 20183:01 pmRNSAppointment of Broker
2nd Mar 201811:01 amRNSStatement re broker
9th Feb 201811:57 amRNSIssue of options and directors dealings
2nd Feb 20184:26 pmRNSHolding(s) in Company
25th Jan 201812:06 pmRNSHolding(s) in Company
23rd Jan 20183:30 pmRNSHolding(s) in Company
16th Jan 20187:00 amRNSValiSeek Clinical Update (VAL401)
11th Jan 20187:00 amRNSUS Patent Notice of Allowance for Compound VAL201
4th Jan 20182:29 pmRNSHolding(s) in Company
3rd Jan 20187:00 amRNSExercise of Warrants and Issue of Equity
27th Dec 201712:54 pmRNSFinal Loan Note Conversion and Issue of Equity
22nd Dec 20177:00 amRNSIssue of Equity
21st Dec 20179:16 amRNSResult of General Meeting
20th Dec 20173:58 pmRNSWarrant Exercise
20th Dec 20173:03 pmRNSWarrant Exercise
18th Dec 20178:45 amRNSWarrant Exercise
18th Dec 20177:00 amRNSre: VAL201 Clinical Trials
15th Dec 20177:00 amRNSExercise of Warrants and Issue of Equity
12th Dec 20177:00 amRNSValiSeek Clinical Development Update
11th Dec 20173:48 pmRNSLoan Note Conversion and Issue of Equity
6th Dec 20177:00 amRNSShareholder Circular and Notice of General Meeting
30th Nov 20172:38 pmRNSIssue of Equity
20th Nov 201711:23 amRNSHolding(s) in Company
15th Nov 20174:37 pmRNSYorkville CLN Conversion

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.